tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market

Theravance Biopharma (TBPH) Cash flow

Compare
311 Followers

Theravance Biopharma Cash Flow

TBPH's free cash flow for Q3 2024 was $-5.21M. For the 2024 fiscal year, TBPH's free cash flow was decreased by $158.08M and operating cash flow was $-5.20M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -27.00M$ -186.99M$ -207.86M$ -250.40M$ -238.20M
Investing Cash Flow
$ -32.70M$ 1.15B$ 124.49M$ 10.72M$ -83.05M
Financing Cash Flow
$ -198.93M$ -758.81M$ 91.86M$ 263.08M$ 1.29M
End Cash Position
$ 40.38M$ 299.01M$ 90.80M$ 82.30M$ 58.90M
Free Cash Flow
$ -29.48M$ -187.56M$ -211.26M$ -257.02M$ -241.37M
Currency in USD

Theravance Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis